MarketResearchReport2021

  Catheter Securement Device Market Growing demand for catheter securement devices in minimally invasive surgeries and technological advancement is expected to register a  CAGR of ~8.2%  during the forecast period of 2021 to 2027 The global  catheter securement device market  is driven by several factors, such as increasing demand forcatheter securement devices used in surgeries, rising incidence, and prevalence ofchronic illness.Furthermore, rising R&D activities for catheter securement devices areprojected to drive the market in the forecast period. Major market players such as 3M company, B. Braun Melsungen AG, C.R. Bard, Inc., ConvaTec Group plc, and Baxter International Inc.are dominating the global catheter securement device market. Theseprominent players are involved in strategic agreements, new product launches, innovations, and joint ventures to sustain their market positions.For instance, in May 2019, Dale Medical Products, Inc. (US) introduced the Hold-n-Place catheter s

  Artificial Cervical Disc Market The global artificial cervical disc market is driven by several factors, such asthe increasing prevalence of orthopedic diseases and degenerative diseases, technological advancements in artificial discs, and the rise of a geriatric population in developed and developing economies. According to MRFR analysis, the global  artificial cervical disc market  is expected to register a  CAGR of ~19% from 2021 to 2027  and hold a value of ~USD 6,262.1 million by 2027. In addition, the artificial cervical disc market is anticipated to grow during the forecast perioddue to the rising healthcare expenditure, supportive reimbursement, growing acceptance of implantation, increasing disposable income, and increasing investments in healthcare infrastructure by the government and private sectors. Get a Sample Report @   https://www.marketresearchfuture.com/sample_request/10608 Major Key Players: Some of the key players in the global artificial cervical disc market are

  Artificial insemination Market Artificial insemination involves depositing sperm into the uterus. In vitro fertilization (IVF) involves extracting the patient's egg cells to be fertilized in a lab. The resultant embryo is then transferred to the uterus. The reimbursement of these techniques is interrelated. Artificial insemination costs hundreds of dollars, while IVF costs thousands. Most of the countries in North America and Europe have a high adoption of treatments related to fertility. The number of cycles of artificial insemination covered differs depending on the country. Global  Artificial Insemination Market  is expected to register a  CAGR of 8.56%  during the forecast period and is expected to hit  USD 3,409.75 Million by 2027 . The province of New Brunswick, Canada, allows individuals to claim up to 50 percent of eligible costs incurred for IVF or IUI and related drugs, up to a maximum of USD 5,000. In France, up to four cycles of ART in women up to the age of 45 are re

  Remdesivir Market Remdesivir is an antiviral drug. FDA approved the remdesivir drug in April 2020 for the clinical trials for COVID 19 treatment. Studies have shown that around 46% of US patients have been recovered from COVID 19 quickly. The growth of the global Remdesivir (COVID 19 )  market can be contributed to the growing need for rescue medication, including remdesivir drugs, due to the outbreak of COVID-19 globally. Furthermore, the rising geriatric population is also expected to fuel market growth during the forecast period. However, the availability of various substitutes for Remdesivir (COVID 19 ) , are expected to restrain the growth of the global Remdesivir (COVID 19 )  market. According to MRFR analysis, Global  Remdesivir (COVID 19) Market  is expected to register a  CAGR of 31.2%  during the forecast period of 2020 to 2027 and reach  USD 10,119.99 Million by 2027. Gilead Sciences, Inc., Bright Gene, Hainan Haiyao, Cipla, Pfizer, Merck, Cayman Chemical, Kelun Pharma, Hu

  COVID Testing Kit Market According to the latest data, there were 86,827 new cases on 16 May 2020 and 7,215,102 new cases on 8 June 2020, globally. Due to such increasing numbers of cases, there is a growing demand for more COVID-19 testing kits and devices, hence driving the market growth. Global  COVID Testing Kit Market  is expected to have a market value of  USD 97,903.2 Million  by 2027. Major Key Players: MRFR recognizes the following companies as the Key Players in the Global COVID Testing Kit— Abbott (US), BioMérieux SA (France), Bio-Rad Laboratories, Inc. (US), Chembio Diagnostic Systems, Inc. (US), Danaher Corporation (US), F. Hoffmann-La Roche Ltd (Switzerland), GenMark (US), Henry Schein, Inc. (US), Thermo Fisher Scientific Inc. (US), Qiagen (Germany), Siemens AG (Germany), Guangzhou Wondfo Biotech (China), Robert Bosch GmbH (Germany), Cellex (US), Mayo Clinic Laboratories (US), Mount Sinai Laboratory (US), Zhejiang Orient Gene Biotech Co., Ltd. (China), Dynamiker Biotech

  AI in Drug Discovery Market The growth of the global AI in drug discovery market is driven by various factors such as investments by industry giants into the AI business, increasing number of startups operating in AI spectrum for healthcare including drug discovery, machine learning, and other AI technologies and increased use of AI technology by major pharma companies in the drug discovery. According to MRFR analysis, the Global  AI in Drug Discovery Market   is expected to register a  CAGR of 40.8%  during the forecast period and is anticipated to reach  USD 2,015.1 Million by 2025. In addition, the increasing number of cross-industry partnerships for achieving the common goal of improvement in the drug development outcomes is another factor for the growth of the AI in the drug discovery market. Below is the chart representing the number of AI-driven deals each of the Big Biopharma companies have disclosed till March 2019. Get a Sample Report @   https://www.marketresearchfuture.co

  Cardiac Biomarkers Market The key factors that drive the cardiac biomarkers market are the increasing prevalence of cardiovascular diseases and lifestyle diseases, increasing prevalence of cardiovascular diseases and lifestyle diseases, increase in demand for disease-specific treatment & research in which cardiac biomarkers are used, technological advancements in cardiac biomarkers, and favorable government initiatives to create awareness related to cardiovascular diseases. However, a lack of awareness among people is expected to hamper market growth. The global  cardiac biomarkers market  is expected to register a  CAGR of 16.36%  during the forecast period and is expected to hit  USD 4236.02 Million by 2027 . There are a number of factors that impact the growth of the cardiac biomarkers market. Some of the key factors include a rise in demand for diagnostic and testing of various cardiovascular diseases, development and advancement in cardiac biomarkers, and growth in the patie

  Thalassemia Treatment Market Thalassemia is an inherited blood disorder that is characterized by inadequate hemoglobin and fewer red blood cells in the body than normal. Hemoglobin is the substance in red blood cells that allows them to carry oxygen. The inadequate hemoglobin and fewer red blood cells of thalassemia may cause anemia. According to MRFR analysis,  Thalassemia Treatment Market   is expected to register a  CAGR of 10.4%  during the forecast period and was valued at  USD 1890.4 Million in 2018. The growth of the Global Thalassemia Treatment Market is driven by various factors such as rising incidence of thalassemia, increasing pipeline drugs in thalassemia, rise in awareness regarding available treatment options for the treatment of thalassemia, growing public awareness related to preventive care and rise in demand for improved curative gene therapy. However, stringent regulatory policies and high treatment costs are expected to curb the growth of the global thalassemia t

  Antibiotic Resistance Market Antimicrobial resistance occurs when microorganisms such as bacteria, viruses, fungi, and parasites change when they are exposed to antimicrobial drugs. Antibiotic drugs include antibiotics, antifungals, antivirals, antimalarials, and anthelmintic. According to MRFR analysis,  Antibiotic Resistance Market   is expected to register a  CAGR of 5.8%  during the forecast period and was valued at  USD 8,120 Million in 2018 . The growth of global antibiotic resistance market is driven by various factors such as -      Rising antibiotic drug resistance infections, rise in the incidence of chronic and infectious disease, increase in clinical developments of antibiotic resistance, and rise in global initiatives to control drug-resistance Several market players currently dominate the global antibiotic resistance market. The key players are involved in product launches and strategic collaborations to strengthen their market positions. Get a Sample Report @   https:/

  Healthcare Cyber Security Market Healthcare cybersecurity has been growing at a rapid pace over the last few years. Cyberattacks in the healthcare industry is one of the primary factors causing a significant loss to the industry. In the last few years, hacking into information and information technology (IT) security breaches have risen at a steady rate, and many healthcare organizations have struggled to prevent their data from cybercrime. Healthcare Cyber Security Market  is expected to register a  CAGR of   11.82%  during the forecast period, with a market value of  USD 16,393.15 Million till 2025. The primary vital factors driving the market growth are the increasing cyberattacks in the healthcare industry, regulatory and government norms to protect patient data, and the growing implementation of mobile device applications and platforms and increased use of Internet of things (IoT) devices in the healthcare sector. However, factors such as lack of adoption of updated software and